tm logo
CRST
Live/Pending
NON-FINAL ACTION - MAILED

final action

on 30 Apr 2024

Last Applicant/ Owned by

640 Memorial Drive, Suite 2300

Cambridge

MA

02139

Serial Number

98201920 filed on 28th Sep 2023

Registration Number

N/A

Correspondent Address

KRISTIN H. ALTOFF MORGAN, LEWIS & BOCKIUS LLP

1111 PENNSYLVANIA AVENUE, NW

WASHINGTON, DC 20004-2541

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CRST

Research and development in the field of technology and engineering RNAs with targeting agents for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of RNA with targeting agents, namely, developing molecular and cellular biology reagents, techniques, and assays for use in the gene editing industry Chemical and biologica Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development in the field of technology and engineering RNAs with targeting agents for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of RNA with targeting agents, namely, developing molecular and cellular biology reagents, techniques, and assays for use in the gene editing industry


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [005]
Pharmaceutical Products


Enzymes, nucleic acid molecules, and compounds/agents for modifying small RNAs with targeting agents for medical use, namely, use of the modified small RNAs in the gene editing industry; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [001]
Chemical Products


Chemical and biological agents for scientific and research use, namely, for the modification of small RNAs with targeting agents and for regulating expression and/or levels of mRNA with the modified RNAs; enzymes for scientific and research purposes; enzyme preparations for use in modifying small RNAs and for use of modified small RNAs in the gene editing industry; Nucleic acid sequences for other than medical and veterinary purposes


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Mark Details


Serial Number

No 98201920

Mark Type

No Service Mark

Attorney Docket Number

No 131399-0003

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
30th Apr 2024NON-FINAL ACTION WRITTEN
30th Apr 2024NON-FINAL ACTION E-MAILED
30th Apr 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
26th Apr 2024ASSIGNED TO EXAMINER
12th Oct 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02th Oct 2023NEW APPLICATION ENTERED